USB U.S. Bancorp

US Bancorp is one of the largest US commercial banks, offering consumer banking, payment services, corporate and commercial banking, and trust and investment management. Sector: Financials.

U.S. Bancorp (USB) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 1.67%, WACC is 5.03%, and the economic spread is -3.36%. On balance, the spread between returns and funding costs is negative — a dynamic that pressures intrinsic value unless operating performance improves. Supporting metrics show ROE at 12.63% and ROA at 1.17%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Assessed on a multiple basis, trailing P/E of 11.39, forward P/E of 10.10, PEG of 2.45. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. Growth-adjusted, the multiple is in an acceptable range — the company is neither pricing in perfection nor offering a meaningful valuation discount. Current ratio data is unavailable in the current snapshot. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

The margin stack reads as follows: gross margin sits at N/A, operating margin at 37.89%, and free cash flow margin at 42.19%. Gross margin data is unavailable in the current snapshot. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. The company's FCF margin is a standout — reflecting businesses where accounting profits translate cleanly into real cash generation. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Where growth and expectations intersect, the estimated 12-month price change of 20.93%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 10.41% suggesting the company is growing revenues at a measured, sustainable pace. Analyst estimates point to EPS growth of 12.8%, suggesting steady earnings progress that supports the current multiple on a forward basis. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

There is enough quality in the profile to avoid outright concern, but not enough uniform strength to take high conviction in a direction. Patience has merit here.

This summary is based on publicly available quantitative data and is not intended as investment advice. Carefully consider your personal financial circumstances before making any decisions.